NCT02269696 is a Phase 3 clinical trial of Metoprolol in Breast Cancer, sponsored by Kuopio University Hospital.

Who is sponsoring NCT02269696?

NCT02269696 is sponsored by Kuopio University Hospital.

What drugs are being tested in NCT02269696?

Interventions in NCT02269696: Metoprolol, Normal saline.

What condition does NCT02269696 study?

NCT02269696 studies Breast Cancer.

Is NCT02269696 still recruiting?

NCT02269696 is currently withdrawn. Last updated 22 March 2018.

Last reviewed 2018-03-22 · How we verify

NCT02269696

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Metoprolol on Anaesthesia, the Need for Analgesics, and Pain in Breast Cancer Patients

Withdrawn Phase 3 Last updated 22 March 2018

What this trial tests

Phase 3 trial testing Metoprolol in Breast Cancer. Withdrawn.

Timeline

21 March 2018

Primary endpoint
21 March 2018

21 March 2018

Quick facts

Lead sponsor	Kuopio University Hospital
Phase	Phase 3
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Start date	21 March 2018
Primary completion	21 March 2018
Estimated completion	21 March 2018

Drugs / interventions tested

Metoprolol (metoprolol) — full drug profile →
Normal saline

Conditions studied

Breast Cancer — all drugs for Breast Cancer →

Sponsor

Kuopio University Hospital

Who can join

Adults 18 to 65, female only, with Breast Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to test the effects of metoprolol on anaesthesia and the need for perioperative analgesics in patients undergoing breast surgery. With 12 months follow-up the incidence of pain and life satisfaction will be evaluated.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Metoprolol

Trials testing the same drug.

NCT06808802 — To Investigate the Effect of Retatrutide (LY3437943) on Metoprolol Pharmacokinetics in Healthy Participants · Phase 1 · completed
NCT06686628 — An Open-label, DDI Study to Investigate the Effects of Amlitelimab on the PK of Selected Cytochrome P450 Substrates · Phase 1 · active not recruiting
NCT06357104 — Detoxification From the Lipid Tract · Phase 4 · completed
NCT05741385 — A Study to Compare How Different Substances (Caffeine, Warfarin, Omeprazole, Metoprolol, and Midazolam) Are Handled by t · NA · completed
NCT05891119 — Study to Investigate the Effect of Rocatinlimab (AMG 451) on the Pharmacokinetics of Multiple Cytochrome P450 (CYP450) S · EARLY_PHASE1 · completed

Other recruiting trials for Breast Cancer

Currently open trials in the same condition.

NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting

Other Kuopio University Hospital trials

Trials by the same sponsor.

NCT06725433 — Nissen Versus Dor Hiatal Hernia Repair · NA · recruiting
NCT06495268 — Healthy heaAring for Healthy Ageing: Data-driven Hearing Rehabilitation Intervention to Promote Healthy Hearing · NA · active not recruiting
NCT06740097 — Feasibility of Aspirate Tissue Monitoring in Neuro-oncological Surgery · NA · recruiting
NCT06460363 — Transcranial Alternating Current Stimulation on Patients with Delirium and Critical Illness (DeliTACS) · NA · recruiting
NCT05863624 — Open and Endoscopic Technique in Female Inguinal Hernia Repair. FemaleHernia · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02269696 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kuopio University Hospital
Last refreshed: 22 March 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02269696.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing